EMA certified  Pharmaceutical manufacturing facility

One of the largest manufacturers of Lopinavir and Ritonavir KSMs and ingredients

View Products


Manufacturing facility

Discovery labs is one of the leading pharmaceutical manufacturing company in Hyderabad with optimized facilities for large scale pharmaceutical manufacturing.


Our commitment to quality and productivity is reflected at every stage of the manufacturing life cycle

Contract Manufacturing

Discovery labs undertakes contract manufacturing of API for various reputed customers like Mylan Labs, Dr. Reddy’s Labs etc.

Environment, health and safety

Discovery believes in sustainable development.

Read More

Why Discovery Pharma?

Discovery labs., the company established in 2006 and is a global player in intermediates and API manufacturing having a strong research and manufacturing team supported by state of the art facility,.

We pride ourselves on being known by our customers for our quality, highly reliable and reputed partner for innovation and complex chemistry

The company has grown consistently to become one of the leading manufacturers of intermediates / Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. has multi product facility in operation

Our Expertise

Research Scientists
KL Reactor capacity
customer audits 2016


N-(4-Amino-1-Benzyl-3-Hydroxy-5-Phenyl-Pentyl)-3-Methyl-2-(2-oxo-Tetrahydro-pyridin-1-yl)-Butyramide-5-oxopyrrolidine-2-carboxylic Acid


[2S,3S,5S]-2-Amino-3-hydroxy-5-(t-butyl carbonyl amino)-1,6- diphenyl hexane (BDH )




tert-Butyl2-(4-(pyridin-2-yl) benzyl) hydrazine carboxylate

Dolutegravir sodium

R-3-Amino Butanol (or) (R) -3-Aminobutan-1-OL
(Under development)



Research and development is one of the means by which business can experience future growth by developing new products or processes to improve and expand their operations

Ability to internalize complex chemistry and deliver consistent results

We are developing non-infringing processes for manufacturing various pharmaceutical ingredient

We have filed for 3 patents in 2014 year for an Anti-retroviral molecule Efavirenz & 1 patent in 2017 for Atazanavir